Tag: biotech

Kaiima

"Kaiima" is a Hebrew word that means "sustainable" or "long-lasting." For Kaiima-the-company, the name reflects its commitment to developing agricultural solutions for growers to improve their crop productivity in a sustainable way. Meet the Israel-based company that has been growing its US operations rapidly out of the Helix Center in St. Louis County.

As Managing Partner of the Life Sciences Fund at Cultivation Capital, Bill Schmidt is currently focused on the venture capital firm’s Life Sciences Fund II. He's dedicated to helping life sciences entrepreneurs take their companies to the next level–and the good news for founders is, he's done it himself. We sat down with Schmidt to hear how he got his start as a founder, and now investor, in St. Louis.
Ginger Imster

Imster has been tasked with promoting our region to startups in the US and around the world. We sat down with her to catch up on the Partnership's upcoming initiatives around innovation and entrepreneurship.
Dollar sign fundraising

Bill Schmidt, Managing Partner of Cultivation Capital's Life Science Fund, shares tips for BioTech companies focused on fundraising.

Affigen, a biotechnology company based in the Cortex Innovation Community that develops therapeutics targeting cell lineage-specific tumor proteins, today announced the closing of a $17 million Series A financing round led by...
Adarza BioSystems

On January 19, startup Adarza BioSystems, Inc, based in St. Louis and Rochester, New York, closed on $17 Million in Series C financing. Here's what the life science company is focused on next.

When Pfizer left St. Louis in 2010, A small team of ex-Pfizer scientists with strong ideas for a new strategic approach to drug discovery research partnered with the St Louis BioGenerator leadership to...

Janus Choice, a company that offers an interactive, mobile, and easy-to-use platform for matching hospital patients with the best post-acute care providers, is growing. Rapidly. So successful has their growth spurt been,...

As the leading cause of mortality in the world—responsible for more than 30 percent of global deaths according to the World Health Organization—the magnitude of of cardiovascular disease can be overwhelming. But...
Bio STL Global STL EQ

How BioSTL’s team is building a relationship with Israel’s startups to grow St. Louis’ ecosystem.

Y Combinator, one of the most prestigious startup incubators in the world, wants to invest in more St. Louis startups. That’s according to the Silicon Valley incubator’s president, Sam Altman, who...

What if the answer to lighting up a room was to have more houseplants? Alexander Krichevsky is founder of Bioglow, a biotech company working on plants as alternatives to electricity-consuming light...

The St. Louis region is currently home to more than 700 bioscience companies employing about 16,500 scientists and staff and the world’s largest concentration of plant science Ph.D.s. This growth has...

An opportunity to interact with scientists and researchers in the St. Louis area at a networking mixer hosted by the Danforth Center's Committee for Scientific Training & Mentoring. There will be...

After leaving the world-renowned Genome Center at Washington University in St. Louis, Jarret Glasscock co-founded Cofactor Genomics, which has been at the forefront of sequencing and analysis of DNA for researchers...

Last summer, BioSTL launched the Bioscience & Entrepreneurial Inclusion Initiative. The goal was simple: Identify promising women and minority entrepreneurs and expose them to opportunities, organizations and connections to help them succeed....

According to Pulse Therapeutics CEO Sean Morris, a company needs two things to succeed in the startup environment.

Our Partners